J. Mol. Med. 2020 Feb 01
Altered molecular signatures during kidney development after intrauterine growth restriction of different origins.
Nüsken E, Fink G, Lechner F, Voggel J, Wohlfarth M, Sprenger L, Mehdiani N, Weber LT, Liebau MC, Brachvogel B, Dötsch J, Nüsken KD
This study was performed to identify transcriptional alterations in male intrauterine growth restricted (IUGR) rats during and at the end of nephrogen ...
Read More
Source: PubMed
Prostaglandins Leukot. Essent. Fatty Acids
Altered plasma prostaglandin E2 levels in epilepsy and in response to antiepileptic drug monotherapy.
Rawat C, Shivangi, Kushwaha S, Sharma S, Srivastava AK, Kukreti R
Prostaglandin E2 (PGE2), a physiologically active lipid compound, is increased in several diseases characterized by chronic inflammation. To determine ...
Read More
Source: PubMed
Environ Int
Association of urinary cadmium, circulating fatty acids, and risk of gestational diabetes mellitus: A nested case-control study in China.
Li X, Huang Y, Xing Y, Hu C, Zhang W, Tang Y, Su W, Huo X, Zhou A, Xia W, Xu S, Chen D, Li Y
Previous studies have observed that cadmium (Cd) exposure of pregnant women was associated with increased risk of gestational diabetes mellitus (GDM). ...
Read More
Source: PubMed
Recent Pat Inflamm Allergy Drug Discov 2020 Jan 29
The Role of Leukotrienes Inhibitors in the Management of Chronic Inflammatory Diseases.
Meshram D, Bhardwaj K, Rathod C, Mahady GB, Soni KK
Leukotrienes are powerful mediators of inflammation and interact with specific receptors in target cell membrane to initiate an inflammatory response. ...
Read More
Source: PubMed
J. Mol. Med. 2020 Feb 01
Altered molecular signatures during kidney development after intrauterine growth restriction of different origins.
Nüsken E, Fink G, Lechner F, Voggel J, Wohlfarth M, Sprenger L, Mehdiani N, Weber LT, Liebau MC, Brachvogel B, Dötsch J, Nüsken KD
This study was performed to identify transcriptional alterations in male intrauterine growth restricted (IUGR) rats during and at the end of nephrogen ...
Read More
Source: PubMed
Prostaglandins Leukot. Essent. Fatty Acids
Inhibition of 20-hydroxyeicosatetraenoic acid (20-HETE) glucuronidation by non-steroidal anti-inflammatory drugs in human liver microsomes and recombinant UDP-glucuronosyltransferase enzymes.
Jarrar YB, Kim DH, Lee SJ, Shin JG
20-hydroxyeicosatetraenoic acid (20-HETE) is an arachidonic acid metabolite which is known to increase platelet aggregation and cardiovascular risk. I ...
Read More
Source: PubMed
Prostaglandins Leukot. Essent. Fatty Acids
Altered plasma prostaglandin E2 levels in epilepsy and in response to antiepileptic drug monotherapy.
Rawat C, Shivangi, Kushwaha S, Sharma S, Srivastava AK, Kukreti R
Prostaglandin E2 (PGE2), a physiologically active lipid compound, is increased in several diseases characterized by chronic inflammation. To determine ...
Read More
Source: PubMed
Environ Int
Association of urinary cadmium, circulating fatty acids, and risk of gestational diabetes mellitus: A nested case-control study in China.
Li X, Huang Y, Xing Y, Hu C, Zhang W, Tang Y, Su W, Huo X, Zhou A, Xia W, Xu S, Chen D, Li Y
Previous studies have observed that cadmium (Cd) exposure of pregnant women was associated with increased risk of gestational diabetes mellitus (GDM). ...
Read More
Source: PubMed
Recent Pat Inflamm Allergy Drug Discov 2020 Jan 29
The Role of Leukotrienes Inhibitors in the Management of Chronic Inflammatory Diseases.
Meshram D, Bhardwaj K, Rathod C, Mahady GB, Soni KK
Leukotrienes are powerful mediators of inflammation and interact with specific receptors in target cell membrane to initiate an inflammatory response. ...
Read More
Source: PubMed
Prostaglandins Leukot. Essent. Fatty Acids
Inhibition of 20-hydroxyeicosatetraenoic acid (20-HETE) glucuronidation by non-steroidal anti-inflammatory drugs in human liver microsomes and recombinant UDP-glucuronosyltransferase enzymes.
Jarrar YB, Kim DH, Lee SJ, Shin JG
20-hydroxyeicosatetraenoic acid (20-HETE) is an arachidonic acid metabolite which is known to increase platelet aggregation and cardiovascular risk. I ...
Read More
Source: PubMed
J. Mol. Med. 2020 Feb 01
Altered molecular signatures during kidney development after intrauterine growth restriction of different origins.
Nüsken E, Fink G, Lechner F, Voggel J, Wohlfarth M, Sprenger L, Mehdiani N, Weber LT, Liebau MC, Brachvogel B, Dötsch J, Nüsken KD
This study was performed to identify transcriptional alterations in male intrauterine growth restricted (IUGR) rats during and at the end of nephrogen ...
Read More
Source: PubMed
Prostaglandins Leukot. Essent. Fatty Acids
Altered plasma prostaglandin E2 levels in epilepsy and in response to antiepileptic drug monotherapy.
Rawat C, Shivangi, Kushwaha S, Sharma S, Srivastava AK, Kukreti R
Prostaglandin E2 (PGE2), a physiologically active lipid compound, is increased in several diseases characterized by chronic inflammation. To determine ...
Read More
Source: PubMed
Environ Int
Association of urinary cadmium, circulating fatty acids, and risk of gestational diabetes mellitus: A nested case-control study in China.
Li X, Huang Y, Xing Y, Hu C, Zhang W, Tang Y, Su W, Huo X, Zhou A, Xia W, Xu S, Chen D, Li Y
Previous studies have observed that cadmium (Cd) exposure of pregnant women was associated with increased risk of gestational diabetes mellitus (GDM). ...
Read More
Source: PubMed
Recent Pat Inflamm Allergy Drug Discov 2020 Jan 29
The Role of Leukotrienes Inhibitors in the Management of Chronic Inflammatory Diseases.
Meshram D, Bhardwaj K, Rathod C, Mahady GB, Soni KK
Leukotrienes are powerful mediators of inflammation and interact with specific receptors in target cell membrane to initiate an inflammatory response. ...
Read More
Source: PubMed
Prostaglandins Leukot. Essent. Fatty Acids
Inhibition of 20-hydroxyeicosatetraenoic acid (20-HETE) glucuronidation by non-steroidal anti-inflammatory drugs in human liver microsomes and recombinant UDP-glucuronosyltransferase enzymes.
Jarrar YB, Kim DH, Lee SJ, Shin JG
20-hydroxyeicosatetraenoic acid (20-HETE) is an arachidonic acid metabolite which is known to increase platelet aggregation and cardiovascular risk. I ...
Read More
Source: PubMed
J. Mol. Med. 2020 Feb 01
Altered molecular signatures during kidney development after intrauterine growth restriction of different origins.
Nüsken E, Fink G, Lechner F, Voggel J, Wohlfarth M, Sprenger L, Mehdiani N, Weber LT, Liebau MC, Brachvogel B, Dötsch J, Nüsken KD
This study was performed to identify transcriptional alterations in male intrauterine growth restricted (IUGR) rats during and at the end of nephrogen ...
Read More
Source: PubMed
Prostaglandins Leukot. Essent. Fatty Acids
Altered plasma prostaglandin E2 levels in epilepsy and in response to antiepileptic drug monotherapy.
Rawat C, Shivangi, Kushwaha S, Sharma S, Srivastava AK, Kukreti R
Prostaglandin E2 (PGE2), a physiologically active lipid compound, is increased in several diseases characterized by chronic inflammation. To determine ...
Read More
Source: PubMed
Environ Int
Association of urinary cadmium, circulating fatty acids, and risk of gestational diabetes mellitus: A nested case-control study in China.
Li X, Huang Y, Xing Y, Hu C, Zhang W, Tang Y, Su W, Huo X, Zhou A, Xia W, Xu S, Chen D, Li Y
Previous studies have observed that cadmium (Cd) exposure of pregnant women was associated with increased risk of gestational diabetes mellitus (GDM). ...
Read More
Source: PubMed
Recent Pat Inflamm Allergy Drug Discov 2020 Jan 29
The Role of Leukotrienes Inhibitors in the Management of Chronic Inflammatory Diseases.
Meshram D, Bhardwaj K, Rathod C, Mahady GB, Soni KK
Leukotrienes are powerful mediators of inflammation and interact with specific receptors in target cell membrane to initiate an inflammatory response. ...
Read More
Source: PubMed
J. Mol. Med. 2020 Feb 01
Altered molecular signatures during kidney development after intrauterine growth restriction of different origins.
Nüsken E, Fink G, Lechner F, Voggel J, Wohlfarth M, Sprenger L, Mehdiani N, Weber LT, Liebau MC, Brachvogel B, Dötsch J, Nüsken KD
This study was performed to identify transcriptional alterations in male intrauterine growth restricted (IUGR) rats during and at the end of nephrogen ...
Read More
Source: PubMed
Prostaglandins Leukot. Essent. Fatty Acids
Inhibition of 20-hydroxyeicosatetraenoic acid (20-HETE) glucuronidation by non-steroidal anti-inflammatory drugs in human liver microsomes and recombinant UDP-glucuronosyltransferase enzymes.
Jarrar YB, Kim DH, Lee SJ, Shin JG
20-hydroxyeicosatetraenoic acid (20-HETE) is an arachidonic acid metabolite which is known to increase platelet aggregation and cardiovascular risk. I ...
Read More
Source: PubMed
Prostaglandins Leukot. Essent. Fatty Acids
Altered plasma prostaglandin E2 levels in epilepsy and in response to antiepileptic drug monotherapy.
Rawat C, Shivangi, Kushwaha S, Sharma S, Srivastava AK, Kukreti R
Prostaglandin E2 (PGE2), a physiologically active lipid compound, is increased in several diseases characterized by chronic inflammation. To determine ...
Read More
Source: PubMed
Environ Int
Association of urinary cadmium, circulating fatty acids, and risk of gestational diabetes mellitus: A nested case-control study in China.
Li X, Huang Y, Xing Y, Hu C, Zhang W, Tang Y, Su W, Huo X, Zhou A, Xia W, Xu S, Chen D, Li Y
Previous studies have observed that cadmium (Cd) exposure of pregnant women was associated with increased risk of gestational diabetes mellitus (GDM). ...
Read More
Source: PubMed
Recent Pat Inflamm Allergy Drug Discov 2020 Jan 29
The Role of Leukotrienes Inhibitors in the Management of Chronic Inflammatory Diseases.
Meshram D, Bhardwaj K, Rathod C, Mahady GB, Soni KK
Leukotrienes are powerful mediators of inflammation and interact with specific receptors in target cell membrane to initiate an inflammatory response. ...
Read More
Source: PubMed
Prostaglandins Leukot. Essent. Fatty Acids
Inhibition of 20-hydroxyeicosatetraenoic acid (20-HETE) glucuronidation by non-steroidal anti-inflammatory drugs in human liver microsomes and recombinant UDP-glucuronosyltransferase enzymes.
Jarrar YB, Kim DH, Lee SJ, Shin JG
20-hydroxyeicosatetraenoic acid (20-HETE) is an arachidonic acid metabolite which is known to increase platelet aggregation and cardiovascular risk. I ...
Read More
Source: PubMed
